Park Avenue Securities’s Insmed INSM Stock Holding History

Park Avenue Securities’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.06M	Sell	9,927 -382	-4%	-$46.3K	0.01%	929
2026 Q1	$1.69M	Buy	+10,309	New	+$1.58M	0.01%	617
2025 Q4	–	Sell	-10,677	Closed	-$1.54M	–	1604
2025 Q3	$1.54M	Sell	10,677 -411	-4%	-$50.4K	0.01%	695
2025 Q2	$1.12M	Buy	11,088 +52	+0.5%	+$3.98K	0.01%	743
2025 Q1	$842K	Buy	11,036 +3,081	+39%	+$236K	0.01%	681
2024 Q4	$549K	Buy	7,955 +2,358	+42%	+$170K	0.01%	1031
2024 Q3	$409K	Buy	5,597 +1,240	+28%	+$91.5K	﹤0.01%	1052
2024 Q2	$292K	Buy	+4,357	New	+$169K	﹤0.01%	1192

Other funds holding INSM

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

GIA

Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

EAM

EULAV Asset Management Sarasota, Florida $3.13B AUM 23.04% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Park Avenue Securities's INSM Position: Q2 2026 in Review

Park Avenue Securities reduced its Insmed (INSM) stake by 3.7% in Q2 2026, selling an estimated $46.3K and leaving 9,927 shares worth $1.06M. The position accounts for 0.01% of the portfolio, ranked #929.

Park Avenue Securities first reported a position in INSM in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.69M in Q1 2026. 169 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Park Avenue Securities held 9,927 shares of Insmed worth $1.06M as of Q2 2026.
Park Avenue Securities sold 382 Insmed shares in Q2 2026, an estimated $46.3K.
Insmed made up 0.01% of Park Avenue Securities's portfolio in Q2 2026, its #929 holding.
Park Avenue Securities first reported a position in Insmed in Q2 2024 and has held it in 8 quarters since.
Park Avenue Securities's Insmed position peaked at $1.69M in Q1 2026.
169 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.